January 23, 2018 / 1:12 PM / 8 months ago

BRIEF-Luye Pharma ‍Updates On Development Of Ansofaxine Hydrochloride Extended Release Tablets​

Jan 23 (Reuters) - Luye Pharma Group Ltd:

* ‍UPDATES ON PHASE II CLINICAL TRIAL IN CHINA FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS​

* PRELIMINARY RESULTS OF PHASE II TRIAL MET PRIMARY EFFICACY ENDPOINT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below